Shareholding disclosure

Endeavour Partners GP Limited

Declared position

2.94%

Threshold

Crossed upwards

Timeline

Published

23.02.2018

Transaction

19.02.2018

Voting rights breakdown

Voting rights acquired2.94%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI2M00054

Beneficial owner

Endeavour Partners GP Limited

Declared address

Endeavour Partners GP Limited, St Peter Port, Guernsey GY1 2HL

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Endeavour Partners GP Limited

Molecular Partners AG23.02.2018TAI2M00054

Disclosure summary

Endeavour Partners GP Limited disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 23.02.2018, at 2.94% of voting rights. Notice category: Single shareholder.

Disclosed position

2.94%

Voting rights acquired

Voting rights acquired2.94%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Endeavour Partners GP Limited disclosed a holding in Molecular Partners AG, published on 23.02.2018.

Publication date23.02.2018

Transaction date19.02.2018

Issuing companyMolecular Partners AG

Beneficial ownerEndeavour Partners GP Limited

Declared addressEndeavour Partners GP Limited, St Peter Port, Guernsey GY1 2HL

CategorySingle shareholder

Voting rights acquired2.94%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAI2M00054

Source: SIX Exchange Regulation · Publication date: 23.02.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open